Leukemia News

The FDA granted accelerated approval to asciminib for the treatment of adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia, according to a press release.

Disparities in hematopoietic stem cell transplantation utilization for blood cancers have narrowed over time but still persist, according to study results.

A new initiative to rapidly place individuals with acute myeloid leukemia or myelodysplastic syndrome in clinical trials based on their genomic profiles has opened in the United States and Canada.

Multiple studies published since this summer suggest chimeric antigen receptor T-cell therapies are comparably effective in real-world settings as they have been in pivotal clinical trials.

In this video, Noah Merin, MD, PhD, discusses the results of a study into the use of timdarpacept for chronic myelomonocytic leukemia, presented at ESMO Congress.

In this video, Noah Merin, MD, PhD, discusses the results of a Chinese study into the use of venetoclax in the treatment of acute myeloid leukemia and non-Hodgkin lymphoma, presented at ESMO Congress.

In this interview, Naval Daver, MD, discusses a session on myelodysplastic syndrome from Society of Hematologic Oncology Annual Meeting.

Naval Daver, MD, spoke with Healio about updates in FLT3-mutated acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.